SUMMARY In a prospective study of Chlamydia trachomatis infection in pregnancy, 198 mothers positive for chlamydial antigen were identified; the infants of 174 were followed for up to six months and C trachomatis was recovered in cell culture from 43 infants (25%). Conjuctivitis occurred in significantly more infants who were positive for C trachomatis (20 of 43, 47%) than in those who were negative (18 of 131, 14%). There were also significantly more lower respiratory tract infections among infants with positive cultures (six of 43, 14%, compared with three of 131, 2%). The chlamydial antigen enzyme linked immunosorbent assay (ELISA) was positive in 61 of 131 infants from whom C trachomatis was not recovered in cell culture. False positive results were usually associated with the isolation of Staphylococcus aureus from samples of pharyngeal aspirate.
Chlamydia trachomatis infection is commonly transmitted from mother to infant in the perinatal period and is now recognised as the commonest cause of neonatal conjunctivitis.' It is also a significant cause of lower respiratory tract infection in infants 3-4 months old2 3 and may be an important pathogen in otitis media. 4 Prospective studies in the United States have reported carriage rates in pregnancy of from 2 to 18%. 9 Transmission occurs in 28-61% of infants of mothers positive for C trachomatis. The incidence of C trachomatis infection in infants has not been documented in Britain, so the value of antenatal screening and treatment in reducing infant morbidity is not known..
We have previously reported the findings of a prospective study of C trachomatis infection in pregnancy in an obstetric population in a district general hospital and explored the maternal risk factors associated with infection and their association with perinatal morbidity and mortality. 10 In the present study we outline the natural history of C trachomatis infection in infants, the rate of transmission, complications of infection, and the persistence of carriage. Such data are necessary to assess the morbidity associated with C trachomatis in the infant population so that the benefits of an antenatal screening programme may be predicted.
Patients and methods
In a prospective study of C trachomatis infection in pregnancy, 3309 unselected women attending a district general hospital obstetric unit, between 1 September 1985 and 31 August 1986, were screened for C trachomatis infection on presentation in labour.
1( An endocervical swab was taken during routine vaginal and speculum examination using a cotton tipped plastic swab. Swabs were placed in transport media, stored at 4°C, and transported to the laboratory. Chlamydial antigen was detected using the Boots Celltech monoclonal antibody enzyme linked immunosorbant assay (ELISA).
As a result of this study 198 women positive for chlamydial antigen were identified. They were offered treatment for themselves and their partners, and invited to bring their infants to the paediatric clinic for follow up. Infants were seen at 3, 6, 12, and 26 weeks. They were examined for evidence of conjunctivitis, respiratory infection, and any other abnormality. At each visit pharyngeal aspirate and cotton tipped plastic swabs from the lower conjunctivae were collected and transported immediately to the laboratory, in chlamydia transport media."
The samples were examined for the presence of chlamydial antigen by a monoclonal antibody ELISA. Samples were also inoculated into cell culture medium containing Buffalo green monkey cells as previously described." The diagnosis was based on the identification of characteristic intracellular inclusion bodies on Giemsa stained monolayers of cells. If all samples were negative on the ELISA on at least two consecutive occasions no further samples were collected and it was assumed that the organism had not been transmitted, though the infants were followed up to act as controls. If the presence of chlamydial antigen was confirmed by the detection of inclusion bodies in cell culture transmission of C trachomatis had occurred.
Infants with respiratory symptoms were investigated to exclude other causal organisms by routine microbiological and virus culture, and immunofluorescence for respiratory syncitial virus, of the nasopharyngeal aspirate. Infants with conjunctivitis were also investigated for other bacterial pathogens.
Infants treated with erythromycin or tetracycline by their general practitioners before investigation were excluded from the study. Symptomatic infants who were positive for C trachomatis were treated with tetracycline oily eye drops for conjunctivitis. Erythromycin (30 mg/kg/day) was added for those who did not respond to tetracycline alone, and was also used to treat infants with lower respiratory tract infections.
Results
During a one year period 198 mothers positive for chlamydial antigen were identified at risk of transmitting C trachomatis to their infants. Seven infants who had been treated with erythromycin or tetracycline before their first follow up visit were excluded, and 16 did not attend for follow up; the parents of one child refused to take part in the study. Infants of 174 mothers positive for chlamydial antigen were therefore followed up. Six further infants were excluded during the study because they were treated with either erythromycin or tetracycline in circumstances outside the protocol.
C trachomatis was cultured on at least one occasion from at least one site in 43 (25%) of the 174 infants (table 1) , and was isolated from two infants who were delivered by elective caesarean section despite intact membranes. It was isolated from the nasopharyngeal aspirate alone in 21 infants, from conjunctival swabs alone in eight, and from both sites in 14. C trachomatis was isolated from 32 of 174 infants (18%) at 3 weeks, decreasing to two of 92 infants (2%) at 26 weeks (figure) Bacterial conjunctivitis occurred in only 18 (14%) of 131 infants negative for C trachomatis, which is significantly less than among the infants who were positive (p<0-0005). These cases were clinically less severe and responded promptly to local treatment with antibiotics. There were no cases of gonococcal conjunctivitis in either group.
RESPIRATORY TRACT INFECTIONS
Six infants positive for C trachomatis (14%) developed lower respiratory tract infections characterised by tachypnoea, hyperinflation, indrawing, and wheeze between 4 and 6 weeks. In each case C trachomatis was grown from phanygeal aspirates at the time of the illness. Three had previously had conjunctivitis; one had been treated with local tetracycline and in the other two the conjunctivitis had resolved without treatment. In one, respiratory syncytial virus shown by immunofluorescence in addition to the C trachomatis. All suffered mild respiratory symptoms, but only one infant required admission to hospital and radiographic changes were minor, consisting only of hyperinflation.
Three infants negative for C trachomatis (2%) had lower respiratory tract infections during the study (p<0005); no organisms were isolated in this group. C trachomatis associated respiratory tract infections resolved promptly in all infants, in two spontaneously and in four after oral treatment with erythromycin. Two infants (one from each group) suffered recurrent purulent otitis media with perforation. In one infant Haemophilus influenzae was isolated from the ear swabs and C trachomatis from pharyngeal aspirate but not from ear swabs. Treatment with amoxycillin was unsuccessful but she responded to erythromycin.
USE OF THE ELISA IN CHILDREN
The ELISA test was positive in 61 of the 131 infants in whom C trachomatis was not subsequently isolated in cell culture; in 53 of these S aureus was also isolated. In one infant a false positive ELISA was associated with the isolation of Candida albicans. False 
in three infants the cell culture was not positive until at least 12 weeks. Presumably only small numbers of organism were acquired at birth and time was required for the organism to replicate sufficiently to yield a positive result in cell culture. Postnatal acquisition, however, cannot be excluded.
C trachomatis is now the commonest cause of neonatal conjunctivitis.1 14 The incidence in this study is higher than that previously reported, '5 16 but this could be due either to a different study design or to a real increase in the prevalence of maternal carriage of the organism.
Presentation before the second week of life is rare, so most children are initially treated by their general practitioners. If the condition is recognised promptly and treated appropriately, response is complete and late complications are rare. Oral erythromycin is now the treatment of choice for C trachomatis conjunctivitis because it is excreted in tears. 17 It also eradicates nasopharyngeal carriage so preventing the respiratory complications that occurred in three of our cases. Ocular prophylaxis with local erythromycin has been attempted in some units in the United States but it is not completely effective in preventing conjunctivitis and in no way alters the incidence of C trachomatis infection in the respiratory tract. 18 Respiratory infections in the first four months are frequently caused by C trachomatis.3 The rate in this study is an underestimate as seven children with conjunctivitis were treated with systemic antibiotics and so were no longer susceptible to C trachomatis respiratory infection, so the true rate was six of 36 (17%). As these seven children suffered the most severe conjunctivitis, the rate in untreated infants may even be higher. The clinical pattern may be indistinguishable from infection with respiratory syncytial virus except that there is no seasonal variation in incidence. Mixed infections may also occur so other respiratory pathogens (including other perinatally acquired organisms such as cytomegalovirus) should be sought.3 13 We found the ELISA a highly efficient method of screening women for chlamydial infection. It was also specific in infants with conjunctivitis, and false positive reactions were rare. 
